Home / Companies / Horizon Therapeutics Public Limited Company / 27 Jul 2023
Horizon Therapeutics Public Limited Company: meeting of 27 Jul 2023
Votes reported on Form N-PX, item by item
691 Form N-PX filers reported votes at the Horizon Therapeutics Public Limited Company meeting of 27 Jul 2023. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
3 nominees; 88.4% of reported votes for; 55 filers withheld from or voted against at least one nominee.
1,146 vote records from 185 filers. 11 of the 185 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
1,012 vote records from 677 filers. 420 of the 646 filers that marked the item either way voted against management. 31 filers reported this item without a management mark.
5 filers reported share counts too large to be the holding described. Those figures are left out of the share split below; the counts of filers include them. How that is decided
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
382 vote records from 185 filers. 5 of the 185 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
59 vote records from 15 filers. 2 of the 15 filers that marked the item either way voted against management.
Several categoriesSecurity holder
Shareholder proposals (not separable from the filings)
Filers described these proposals in wordings that could not be matched to one another, so they are shown together.
1 vote records from 1 filers. 0 of the 1 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | For | Against * | For |
| Dimensional | For | Against * | For |
| State Street and SPDR | For | For | For |
| American Century | For | Against * | For |
| Franklin Templeton | For | Against * | For |
| Invesco | For | For | For |
| Equitable | For | Against * | For |
| Charles Schwab | For | Against * | For |
| Nuveen and TIAA | For | For | For |
| ProShares and ProFunds | For | Against * | For |
| John Hancock and Manulife | For | Against * | For |
| Morgan Stanley, Eaton Vance and Calvert | Against * | Against * | For |
| J.P. Morgan | For | For | For |
| Goldman Sachs | For | Against * | For |
| WisdomTree | For | Against * | For |
| PGIM and Prudential | For | Against * | For |
| Jackson National funds | For | Against * | For |
| Northern Trust and FlexShares | For | For | For |
| SEI | For | Against * | For |
| T. Rowe Price | For | Against * | For |
| Lincoln Financial | For | Against * | For |
| Voya | For | Against * | For |
| First Trust | For | Against * | For |
| Russell Investments | For | Against * | For |
| Nationwide | For | Against * | For |
| Victory Capital | For | Against * | For |
| Brighthouse Funds | For | Against * | For |
| Guggenheim and Rydex | For | Against * | For |
| Columbia Threadneedle | For | Against * | For |
| BNY Mellon | For | For | For |
| Principal | For | Against * | For |
| Capital Group and American Funds | For | For | For |
| Pacific Life funds | For | For | For |
| Global X | For | Against * | For |
| Transamerica | For | Against * | For |
| Federated Hermes | No report | For | No report |
| AllianceBernstein | For | Against * | For |
| DWS | No report | Against * | No report |
| PIMCO | For | Against * | For |
| Allspring | For | Against * | For |
| MassMutual | No report | For | No report |
| Virtus | For | For | For |
| Macquarie and Delaware Funds | No report | Against * | No report |
| Janus Henderson | No report | Against * | No report |
| Neuberger Berman | For | Against * | For |
| Natixis and Loomis Sayles | For | Against * | For |
| Baird | No report | Against * | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Horizon Therapeutics Public Limited Company meeting?
691 Form N-PX filers reported votes at the meeting of 27 Jul 2023. On say-on-pay, 420 of 646 voted against management (65.0%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Horizon Therapeutics Public Limited Company on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Horizon Therapeutics Public Limited Company
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Horizon Therapeutics Public Limited Company with a meeting date within three days of 27 Jul 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.